The cancer kept coming back

His life was blasted apart by a rare but vicious type of cancer. Could an experimental treatment help? When Derek Fadness woke up, the room was dark and his face was swaddled in bandages. He could...

Knight Cancer signal achievements of 2022

People at the Knight Cancer Institute accomplished a lot in 2022. Through innovative, collaborative research and education, the institute delivers cancer prevention, detection, and care — one...

A better roadmap for beating a deadly leukemia

Acute myeloid leukemia, or AML, is the most common acute blood cancer in adults — and one of the most difficult to treat. Scientists at Oregon Health & Science University have discovered a...

New approach finds drug combinations to stop cancer

In the future, the most effective cancer drug therapies will likely be combinations that not only target cancer cells but also drive cancer-suppressing responses in non-cancer cells in and around...

New treatment strategy aims to stop rare liver cancer

An OHSU surgeon’s innovative approach targets deadly cholangiocarcinoma of the liver.   Jerry Widawski knew the statistics were not in his favor. At age 68, he was diagnosed with a rare...

Treatment advance for an incurable blood cancer

Researchers are reporting an impressive advance in the treatment of mantle cell lymphoma, a type of blood cancer that is considered incurable. Patients who took the drug ibrutinib in addition to a...